Inventor
TRIEU VUONG
US35 patents
⚠️ This page may combine multiple inventors who share the name “TRIEU VUONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABRAXIS BIOSCIENCE LLC
18 patentsUS7923536B2Apr 12, 2011
Compositions and methods of delivery of pharmacological agents
ABRAXIS BIOSCIENCE LLC160 citations99
US7820788B2Oct 26, 2010
Compositions and methods of delivery of pharmacological agents
ABRAXIS BIOSCIENCE LLC211 citations99
US9295733B2Mar 29, 2016
SPARC binding ScFcs
ABRAXIS BIOSCIENCE LLC35 citations98
US9012518B2Apr 21, 2015
Compositions and methods of delivery of pharmacological agents
ABRAXIS BIOSCIENCE LLC36 citations98
US9012519B2Apr 21, 2015
Compositions and methods of delivery of pharmacological agents
ABRAXIS BIOSCIENCE LLC38 citations98
US8846771B2Sep 30, 2014
Compositions and methods of delivery of pharmacological agents
ABRAXIS BIOSCIENCE LLC48 citations98
US8383358B2Feb 26, 2013
Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy
ABRAXIS BIOSCIENCE LLC2 citations58
US10053504B2Aug 21, 2018
SPARC binding ScFvs
ABRAXIS BIOSCIENCE LLC0 citations52
US9671406B2Jun 6, 2017
SPARC and methods of use thereof
ABRAXIS BIOSCIENCE LLC0 citations52
US9314537B2Apr 19, 2016
SPARC binding ScFcs
ABRAXIS BIOSCIENCE LLC0 citations52
US9308279B2Apr 12, 2016
SPARC binding ScFvs
ABRAXIS BIOSCIENCE LLC0 citations52
US8946169B2Feb 3, 2015
SPARC and methods of use thereof
ABRAXIS BIOSCIENCE LLC0 citations52
US8916204B2Dec 23, 2014
SPARC and methods of use thereof
ABRAXIS BIOSCIENCE LLC0 citations52
US8821836B2Sep 2, 2014
SPARC binding peptides and uses thereof
ABRAXIS BIOSCIENCE LLC0 citations52
US7674816B2Mar 9, 2010
Substituted melatonin derivatives, process for their preparation, and methods of use
ABRAXIS BIOSCIENCE LLC1 citations52
US9091697B2Jul 28, 2015
Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma
ABRAXIS BIOSCIENCE LLC0 citations48
US8026275B2Sep 27, 2011
Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
ABRAXIS BIOSCIENCE LLC0 citations41
US7799954B2Sep 21, 2010
Dicarbonyl derivatives and methods of use
ABRAXIS BIOSCIENCE LLC0 citations41
TRIEU VUONG
6 patentsUS8415304B2Apr 9, 2013
Sparc and methods of use thereof
TRIEU VUONG15 citations92
US8420603B2Apr 16, 2013
SPARC and methods of use thereof
TRIEU VUONG11 citations83
US8809507B2Aug 19, 2014
SPARC binding ScFvs
TRIEU VUONG0 citations51
US8445637B2May 21, 2013
SPARC binding peptides and uses thereof
TRIEU VUONG0 citations51
US9096660B2Aug 4, 2015
SPARC binding antibodies and uses thereof
TRIEU VUONG0 citations48
US9193782B2Nov 24, 2015
Use of the SPARC microenvironment signature in the treatment of cancer
TRIEU VUONG0 citations38
AUTOTELIC LLC
6 patentsUS9758786B2Sep 12, 2017
Compositions and methods for treating pancreatic cancer
AUTOTELIC LLC2 citations72
US9989543B2Jun 5, 2018
Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension
AUTOTELIC LLC0 citations51
US9963703B2May 8, 2018
Compositions and methods for treating pancreatic cancer
AUTOTELIC LLC0 citations51
US9678078B2Jun 13, 2017
Methods and compositions for personalized medicine by point-of-care devices for brain natriuretic peptide
AUTOTELIC LLC1 citations51
US9763892B2Sep 19, 2017
Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
AUTOTELIC LLC1 citations49
US9964551B2May 8, 2018
Antibody-based affinity reagents for binding paclitaxel
AUTOTELIC LLC0 citations32
DESAI NEIL P
3 patentsUS8314156B2Nov 20, 2012
Compositions and methods of delivery of pharmacological agents
DESAI NEIL P137 citations99
US8138229B2Mar 20, 2012
Compositions and methods of delivery of pharmacological agents
DESAI NEIL P160 citations99
US8911786B2Dec 16, 2014
Nanoparticle comprising rapamycin and albumin as anticancer agent
DESAI NEIL P76 citations98